Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| LILRA1 | LILRA1-HB001 | Human | HEK293 | Biotinylated Human LILRA1/CD85i/LIR-6 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRA1 (17–461) AviHis |
| HBV | HBV-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HBV (25–305) AviHis |
| HLA-E*01:03 | HLAE0103-HB003 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-E*01:03&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| KRAS G12D | KRASG12D-HB004 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB014 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*02:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| CMV pp65 | CMVPP65-HB003 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | CMV pp65 (25–305) AviHis |
| HLA-A*24:02 | HLAA2402-HP001 | Human | HEK293 | Human Peptide Ready HLA-A*24:02&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*24:02 (25–305) AviHis |
| KRAS WT | KRASWT-HB003 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS WT (25–305) AviHis |
| HLA-A*24:02 | HLAA2402-HB002 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*24:02 (25–305) AviHis |
| HLA-B*27:05 | HLAB2705-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-B*27:05&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-B*27:05 (25–305) AviHis |
| LILRA5 | LILRA5-HB001 | Human | HEK293 | Biotinylated Human LILRA5/CD85f/ILT11 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRA5 (42–268) AviHis |
| HLA-E*01:03 | HLAE0103-HP003 | Human | HEK293 | Human HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| CD8 | CD8-HF001 | Human | HEK293 | Human CD8 alpha/CD8A Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg | CD8 (22–182) Fc |
| CD74 | CD74-HB001 | Human | HEK293 | Biotinylated Human CD74/DHLAG Protein (Primary Amine Labeling) Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CD74 (73–232) His |
| CD8 | CD8-HB002 | Human | HEK293 | Biotinylated Human CD8 alpha&beta Heterodimer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CD8 (22–182) AviHisFLAG |
| LILRA3 | LILRA3-HB001 | Human | HEK293 | Biotinylated Human LILRA3/CD85e Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRA3 (24–439) AviHis |
| MICA | MICA-HB001 | Human | HEK293 | Biotinylated Human MICA Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MICA (24–308) AviHis |
| FcRn | FCRN-AB001 | Human | HEK293 | Anti-FcRn Antibody (Rozanolixizumab Biosimilar) Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | FcRn |
| LILRB3 | LILRB3-HB001 | Human | HEK293 | Biotinylated Human LILRB3/CD85a/ILT5 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRB3 (24–443) AviHis |
| CD8 | CD8-HB001 | Human | HEK293 | Biotinylated Human CD8 alpha/CD8A Protein Purity > 95% as determined by Bis-Tris PAGE Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CD8 (22–182) AviHis |